Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone

Journal of Bone and Mineral Research

Volumn 17, Issue 9, 2002, Pages 1570-1578

  Bikle, Daniel D ^a   Sakata, Takeshi ^a   Leary, Colin ^a   Elalieh, Hashem ^a   Ginzinger, David ^a   Rosen, Clifford J ^b   Beamer, Wesley ^c   Majumdar, Sharmila ^d   Halloran, Bernard P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b St Josephs Hospital   (United States)

^c JACKSON LABORATORY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone density; Bone formation; Differentiation; Homologous recombination; Osteoblast

Indexed keywords

ANABOLIC AGENT; PARATHYROID HORMONE; SOMATOMEDIN C; ALKALINE PHOSPHATASE; COLLAGEN; MESSENGER RNA; OSTEOCALCIN; PARATHYROID HORMONE RECEPTOR; SOMATOMEDIN C RECEPTOR;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE METABOLISM; BONE MINERAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CORTICAL BONE; GENETIC RECOMBINATION; HORMONE ACTION; MOUSE; NONHUMAN; OSTEOBLAST; STROMA CELL; THICKNESS; TRABECULAR BONE; ANIMAL; BONE; BONE DENSITY; BONE DEVELOPMENT; DRUG EFFECT; GENETICS; HETEROZYGOTE; HISTOLOGY; HOMOZYGOTE; MALE; METABOLISM; MOUSE MUTANT; NASA DISCIPLINE MUSCULOSKELETAL; NON-NASA CENTER; PHYSIOLOGY;

ALKALINE PHOSPHATASE; ANIMAL; BONE AND BONES; BONE DENSITY; COLLAGEN; HETEROZYGOTE; HOMOZYGOTE; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PARATHYROID HORMONES; RECEPTOR, IGF TYPE 1; RECEPTORS, PARATHYROID HORMONE; RNA, MESSENGER; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; PARATHYROID HORMONE;

NASA DISCIPLINE MUSCULOSKELETAL; NON-NASA CENTER;

EID: 0036708145     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2002.17.9.1570     Document Type: Article

References (32)

1. Anabolic actions of parathyroid hormone on bone
2. Regional responsiveness of the tibia to intermittent administration of parathyroid hormone as affected by skeletal unloading
3. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells
4. Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I
5. Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow
6. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
7. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone
8. Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats
9. Parathyroid hormone stimulates release of insulin-like growth factor-1 (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture
10. Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures
11. Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures
12. Transforming growth factor-beta stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae
13. IGF-I is required for normal embryonic growth in mice
14. Differentiating between orchiectomized rats and controls using measurements of trabecular bone density: A comparison among DXA, histomorphometry, and peripheral quantitative computerized tomography
15. The skeletal structure of insulin-like growth factor-I deficient mice
16. Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities
17. Real time quantitative PCR
18. Measurement of DNA copy number at microsatellite loci using quantitative real time PCR analysis
19. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
20. The mitogenic effect of parathyroid hormone is associated with E2F-dependent activation of cyclin-dependent kinase 1 (cdc2) in osteoblast precursors
21. Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH-(1-34)
22. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation
23. Multiple extracellular signals promote osteoblast survival and apoptosis
24. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells
25. Effects of Igf1 gene deletion on postnatal growth patterns
26. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)
27. Role of insulin-like growth factors in embryonic and postnatal growth
28. Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosagedependent manner: Manipulation using the Cre/loxP system in transgenic mice
29. Expression of the genes for the insulin-like growth factors in bone during skeletal growth
30. A growth factor deficiency phenotype in heterozygous mice carrying an insulin-like growth factor-II gene disruption
31. Regional responsiveness of the tibia to intermittent administration of parathyroid hormone as affected by skeletal unloading
32. Evidence that anabolic effects of PTH on bone require IGF-I in growing mice